Connection

Kwok-Yung Yuen to Drug Therapy, Combination

Back to Details
This is a "connection" page, showing publications Kwok-Yung Yuen has written about Drug Therapy, Combination.
Kwok-Yung Yuen
Connection Strength
0.199
Drug Therapy, Combination
  1. Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. Lancet. 2020 05 30; 395(10238):1695-1704.
    View in: PubMed
    Score: 0.077
  2. Triple combination of FDA-approved drugs including flufenamic acid, clarithromycin and zanamivir improves survival of severe influenza in mice. Arch Virol. 2018 Sep; 163(9):2349-2358.
    View in: PubMed
    Score: 0.067
  3. Medical treatment of viral pneumonia including SARS in immunocompetent adult. J Infect. 2004 Nov; 49(4):262-73.
    View in: PubMed
    Score: 0.026
  4. Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection. Emerg Microbes Infect. 2021 Dec; 10(1):291-304.
    View in: PubMed
    Score: 0.022
  5. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax. 2004 Mar; 59(3):252-6.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.